
To be announced
Christoffer Joys Røang, Co-founder – Chief Commercial Officer, Kelpinor AS, Norway

To be announced
Christoffer Joys Røang, Co-founder – Chief Commercial Officer, Kelpinor AS, Norway
About the speaker:
Chris Co-founded Kelpinor 4 years ago and today he is the Chief Commercial Officer at the company. Christoffer loves a good challenge and proving that everything is possible if you just put your mind to it. His main focus day to day is introducing cultivated biostimulants to the Agri sector in Europe, Christoffer has previously been in charge projects at Kelpinor like design and deployment of the first farm, building and running northern Norway's biggest cultivated seaweed processing facility and designed the machines used to create their biostimulants. He is now spearheading Kelpinor's push towards biostimulants from cultivated seaweed.
Company info:

Kelpinor as a company has the humble goal of creating a new sustainable large-scale ocean-based industry in Norway. They do this by developing and selling plant biostimulants intended for agriculture and recreational users alike, all made from Norwegian cultivated kelp. Their products are currently sold in Germany, Norway, Sweden, Netherlands, Austria, Switzerland, France, Spain with more countries to follow shortly. Kelpinor's proprietary production process allows them to keep more of the bioactive compounds present and available to the plants resulting in a wide range of effects helping the plants deal with abiotic stresses like temperature, flooding, drought, light and mechanical stress all making the farmer less dependent on perfect weather conditions while increasing yield.
Presentation:
Cultivated seaweed biostimulants is the next chapter in both the world of conventional and sustainable agriculture. Unlocking access to increased yield, improved quality and less loss due to abiotic stress. But how will Kelpinor convince an industry known for being slow and stubborn to replace their beloved wild harvested ascophyllum with a new species and how does the effect of Alaria compare to Asco?